Identification | Back Directory | [Name]
Thalidomide-NH-PEG2-C2-NH2 (TFA) | [CAS]
2097509-36-7 | [Synonyms]
Thalidomide-NH-PEG2-NH2 TFA Thalidomide-4-NH-PEG2-NH2 TFA Thalidomide-PEG2-C2-NH2 (TFA) Thalidomide-NH-PEG2-C2-NH2 (TFA) | [Molecular Formula]
C21H25F3N4O8 | [MDL Number]
MFCD32690100 | [MOL File]
2097509-36-7.mol | [Molecular Weight]
518.45 |
Hazard Information | Back Directory | [Uses]
Thalidomide-PEG2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology[1]. | [IC 50]
Cereblon | [References]
[1] Wang Z, et al. Proteolysis Targeting Chimeras for the Selective Degradation of Mcl-1/Bcl-2 Derived from Nonselective Target Binding Ligands. J Med Chem. 2019 Sep 12;62(17):8152-8163. DOI:10.1021/acs.jmedchem.9b00919 |
|
|